Estimating regional variation in cancer survival: A tool for improving cancer care

Cancer Causes and Control

Volumn 15, Issue 6, 2004, Pages 611-618

  Yu, Xue Q ^a   O'Connell, Dianne L ^a   Gibberd, Robert W ^b   Smith, David P ^a   Dickman, Paul W ^c   Armstrong, Bruce K ^d  

^a CANCER RESEARCH DIVISION   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

cancer; empirical Bayes methods; regional variation; relative survival

Indexed keywords

AGE DISTRIBUTION; ARTICLE; AUSTRALIA; BAYES THEOREM; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CAUSE OF DEATH; DISEASE SEVERITY; EMPIRICISM; GEOGRAPHIC DISTRIBUTION; HUMAN; LUNG CANCER; MATHEMATICAL MODEL; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; BAYES THEOREM; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; NEW SOUTH WALES; PROGNOSIS; REGISTRIES; SURVIVAL ANALYSIS;

EID: 4043164872     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CACO.0000036165.13089.e8     Document Type: Article

References (29)

1. Dickman PW, Gibberd RW, Hakulinen T (1997) Estimating potential savings in cancer deaths by eliminating regional and social class variation in cancer survival in the Nordic countries. J Epidemiol Commun Health 51: 289-298.
2. Farrow DC, Samet JM, Hunt WC (1996) Regional variation in survival following the diagnosis of cancer. J Clin Epidemiol 49: 843-847.
3. Twelves CJ, Thomson CS, Dewar JA, Brewster DH (2001) Variation in survival of women with breast cancer: Health Board remains a factor at 10 years. Br J Cancer 85: 637-640.
4. The Canadian Institute for Health Information. Location plays role in cancer survival: study. Available at: http://www.cbc.ca/stories/2002/05/30/ cancer_report020530, accessibility verified June 13, 2002.
5. Cole P, Morrison AS (1980) Basic issues in population screening for cancer. J Natl Cancer Inst 64: 1263-1272.
6. Black WC, Welch HG (1993) Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med 328: 1237-1243.
7. Jacobson B, Mindell J, McKee M (2003) Hospital mortality league tables: question what they tell you-and how useful they are. BMJ 326: 777-778.
8. Efron B, Morris C (1975) Data analysis using Stein's estimator and its generalizations. J Am Stat Assoc 70: 311-319.
9. Christiansen CL, Morris CN (1997) Improving the statistical approach to health care provider profiling. Annal Int Med 127: 764-768.
10. Gibberd R, Pathmeswaran A, Burtenshaw K (2000) Using clinical indicators to identify areas for quality improvement. J Qual Clin Practice 20: 136-144.
11. Spiegelhalter DJ, Myles JP, Jones DR, et al. (1999) An introduction to Bayesian methods in health technology assessment. BMJ 319: 508-512.
12. Brenner H, Soderman B, Hakulinen T (2002) Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol 31: 456-462.
13. Ederer F, Axtell LM, Cutler SJ (1961) The relative survival rate: a statistical methodology. Natl Cancer Inst Monograph 6: 101-121.
14. Chiang CL (1968) Introduction to Stochastic Processes in Biostatistics. New York: John Wiley.
15. Ederer F, Heise H (1959) Instructions to IMB 650 programmers in processing survival computations. Methodological Note No. 10, End Results Evaluation Section. Bethesda, MD: National Cancer Institute.
16. Voutilainen ET, Dickman PW, Hakulinen T (2000) SURV2: Relative Survival Analysis Program. Software Manual (Version 2.02β). Helsinki: Finnish Cancer Registry.
17. Suissa S (1999) Relative excess risk: an alternative measure of comparative risk. Am J Epidemiol 150: 279-282.
18. Cancer Strategies Group (2001) Priorities for Action in Cancer Control 2001-2003. Canberra: Commonwealth of Australia, pp. 9-12.
19. Howley P, Gibberd R (2003) Using hierarchical models to analyse clinical indicators: a comparison of the gamma-Poisson and beta-binomial models. Int J Qual Health Care 15: 919-929.
20. Australian Council on Healthcare Standards (2003) Determining the Potential to Improve the Quality of Care, 3rd edn. ACHS Clinical Indicator Results for Australia and New Zealand 1998-2001. Sydney: The Australian Council on Healthcare Standards.
21. Supramaniam R, Smith DP, Coates MS, Armstrong BK (1999) Survival from Cancer in New South Wales in 1980 to 1995. Sydney: NSW Cancer Council.
22. Clinical Governance Unit (2002) The National Colorectal Cancer Care Survey. Australian Clinical Practice in 2000. Melbourne: National Cancer Control Initiative.
23. Accounts Commission for Scotland (1998) Fighting the Silent Killer: Optimising Ovarian Cancer Management in Scotland. Edinburgh: Accounts Commission for Scotland.
24. Goodwin JS, Freeman JL, Mahnken JD, Freeman DH, Nattinger AB (2002) Geographic variations in breast cancer survival among older women: implications for quality of breast cancer care. J Gerontol A Biol Sci Med Sci 57: M401-M406.
25. Cartman ML, Hatfield AC, Muers MF, Peake MD, Haward RA, Forman D (2002) Lung cancer: district active treatment rates affect survival. J Epidemiol Commun. Health 56: 424-429.
26. Karjalainen S (1990) Geographical variation in cancer patient survival in Finland: chance, confounding, or effect of treatment? J Epidemiol Community Health 44: 210-214.
27. Campbell NC, Elliott AM, Sharp L, Ritchie LD, Cassidy J, Little J (2000) Rural factors and survival from cancer: analysis of Scottish cancer registrations. Br J Cancer 82: 1863-1866.
28. Gatta G, Buiatti E, Conti E, et al. (1997) Variations in the survival of adult cancer patients in Italy. Tumori 83: 497-504.
29. Madsen FF, Norskov B, Frolund L, Hanash JA (2002) Lung cancer: survival rate differences in Danish counties. Survival analysis of 33,838 patients during the period 1984-1998. Ugeskr Laeger 164: 483-487.